A Study to Assess ASP0598 Otic Solution Following Topical Application in the Ear in Subjects With Chronic Tympanic Membrane Perforation (CTMP)

NCT04305184 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

36

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of Efficacy

Conditions

Chronic Tympanic Membrane Perforation

Interventions

DRUG: ASP0598
OTHER: Placebo

Sponsor

Astellas Pharma Global Development, Inc.